June 26 (UPI) -- Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants By Annika Kim Constantino, CNBC • Published June 26, 2025 • Updated on June 26, 2025 at 12:52 pm ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot that can protect babies from respiratory syncytial virus, adding an ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted to recommend use of a new Merck shot that can protect babies from respiratory syncytial virus.

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has previously made statements skeptical of vaccines, is now recommending the respiratory syncytial virus (RSV) vaccine for ...

Merck MRK announced that the FDA has accepted the biologics license application (BLA) for its investigational prophylactic long-acting monoclonal antibody, clesrovimab (MK-1654), designed to ...

A committee that advises the Centers for Disease Control and Prevention on vaccines voted Thursday to recommend the use of a new preventative therapy for RSV in babies, Merck’s Enflonsia.&# ...

New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies By Meg Tirrell, CNN Jun 26, 2025 ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted to recommend use of a new Merck shot that can protect babies from respiratory syncytial virus.